Published in Rheum Dis Clin North Am on May 01, 2010
Understanding immunosenescence to improve responses to vaccines. Nat Immunol (2013) 2.09
Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J Exp Med (2013) 1.96
Immune aging and autoimmunity. Cell Mol Life Sci (2012) 1.19
Chronic inflammation and aging: DNA damage tips the balance. Curr Opin Immunol (2012) 1.13
The janus head of T cell aging - autoimmunity and immunodeficiency. Front Immunol (2013) 1.09
Discrimination, racial bias, and telomere length in African-American men. Am J Prev Med (2014) 1.04
The role of the T cell in age-related inflammation. Age (Dordr) (2012) 1.00
IL-7- and IL-15-mediated TCR sensitization enables T cell responses to self-antigens. J Immunol (2013) 0.99
T-cell metabolism in autoimmune disease. Arthritis Res Ther (2015) 0.95
Mechanisms of immunosenescence: lessons from models of accelerated immune aging. Ann N Y Acad Sci (2012) 0.93
Mechanisms shaping the naïve T cell repertoire in the elderly - thymic involution or peripheral homeostatic proliferation? Exp Gerontol (2014) 0.87
The influence of ageing on the development and management of rheumatoid arthritis. Nat Rev Rheumatol (2013) 0.85
Downregulation of inhibitory SRC homology 2 domain-containing phosphatase-1 (SHP-1) leads to recovery of T cell responses in elderly. Cell Commun Signal (2014) 0.81
Immunosenescence, aging, and systemic lupus erythematous. Autoimmune Dis (2013) 0.80
Age-Related Disruption of Steady-State Thymic Medulla Provokes Autoimmune Phenotype via Perturbing Negative Selection. Aging Dis (2012) 0.80
Defective CD8+CD28+ regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy. Clin Exp Immunol (2013) 0.80
Aging of the Immune System. Mechanisms and Therapeutic Targets. Ann Am Thorac Soc (2016) 0.78
Telomere Length and Coronary Atherosclerosis in Rheumatoid Arthritis. J Rheumatol (2016) 0.75
Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions. Int J Clin Rheumtol (2015) 0.75
Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patients. Arthritis Res Ther (2016) 0.75
Low vaccination rates among patients with rheumatoid arthritis in a German outpatient clinic. Rheumatol Int (2016) 0.75
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
How shelterin protects mammalian telomeres. Annu Rev Genet (2008) 11.20
Changes in thymic function with age and during the treatment of HIV infection. Nature (1998) 10.27
Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med (2007) 7.29
Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell (2004) 5.59
Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet (2005) 4.88
The influence of age on T cell generation and TCR diversity. J Immunol (2005) 4.36
Aging of the immune system: how much can the adaptive immune system adapt? Immunity (2006) 4.30
Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum (2002) 4.23
Medium- and large-vessel vasculitis. N Engl J Med (2003) 3.96
The incidence of herpes zoster. Arch Intern Med (1995) 3.87
Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med (2000) 3.70
Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med (2003) 3.48
Perturbation of the T-cell repertoire in patients with unstable angina. Circulation (1999) 3.20
T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 3.06
CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest (1996) 2.95
Age-dependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest (2005) 2.84
Telomeres in T and B cells. Nat Rev Immunol (2002) 2.76
The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev (2005) 2.62
Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat Rev Immunol (2008) 2.58
Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation (2000) 2.56
T cell subset-specific susceptibility to aging. Clin Immunol (2008) 2.42
Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci U S A (1998) 2.33
Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum (2010) 2.29
T cell development and receptor diversity during aging. Curr Opin Immunol (2005) 2.29
Aging, immunity, and the varicella-zoster virus. N Engl J Med (2005) 2.20
Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum (1997) 2.11
Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum (2004) 2.08
The aging of the immune system. Adv Immunol (2002) 1.96
Rheumatoid arthritis. Immunol Rev (2005) 1.94
A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation (1999) 1.93
Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol (2004) 1.89
Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis. Arthritis Rheum (2005) 1.88
IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H). J Clin Invest (2009) 1.87
The aging innate immune system. Curr Opin Immunol (2005) 1.81
Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine (2007) 1.78
Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Circulation (2006) 1.77
T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation (2002) 1.72
Down-regulation of CD28 expression by TNF-alpha. J Immunol (2001) 1.65
Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci U S A (2003) 1.65
T cell recognition and killing of vascular smooth muscle cells in acute coronary syndrome. Circ Res (2006) 1.62
Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther (2003) 1.61
Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics. Crit Rev Immunol (2003) 1.58
Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis. Blood (2002) 1.57
Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci U S A (2009) 1.54
Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis. J Exp Med (2009) 1.54
T cell receptor gene deletion circles identify recent thymic emigrants in the peripheral T cell pool. Proc Natl Acad Sci U S A (1999) 1.54
Thymic output: a bad TREC record. Nat Immunol (2003) 1.50
TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J Exp Med (2006) 1.48
Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis. Trends Immunol (2001) 1.39
Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther (2005) 1.38
Developments in the scientific understanding of rheumatoid arthritis. Arthritis Res Ther (2009) 1.38
Pathogenesis of rheumatoid arthritis. Med Clin North Am (1997) 1.35
T cells in rheumatoid arthritis. Arthritis Res Ther (2008) 1.33
Rejuvenating the immune system in rheumatoid arthritis. Nat Rev Rheumatol (2009) 1.29
Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum (2008) 1.25
Telomeres and immunological diseases of aging. Gerontology (2009) 1.22
CD28 loss in senescent CD4+ T cells: reversal by interleukin-12 stimulation. Blood (2002) 1.21
Dendritic cells in atherosclerotic disease. Clin Immunol (2009) 1.17
The repertoire of CD4+ CD28- T cells in rheumatoid arthritis. Mol Med (1996) 1.16
Emergence of oligoclonal T cell populations following therapeutic T cell depletion in rheumatoid arthritis. Arthritis Rheum (1995) 1.15
Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. Arthritis Rheum (1996) 1.13
T cells in arteritis and atherosclerosis. Curr Opin Lipidol (2008) 1.10
Autoimmune diabetes mellitus in the BB rat. Diabetes Metab Rev (1992) 1.08
T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis. Arthritis Rheum (2005) 1.08
ERK-dependent T cell receptor threshold calibration in rheumatoid arthritis. J Immunol (2009) 1.06
Cell-based immunotherapy with suppressor CD8+ T cells in rheumatoid arthritis. J Immunol (2005) 1.05
Analyses of immunosenescent markers in patients with autoimmune disease. Clin Immunol (2007) 1.03
Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomes. Arthritis Rheum (2008) 1.01
Immune receptor signaling, aging and autoimmunity. Adv Exp Med Biol (2008) 1.00
Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H. Immunology (1996) 0.99
Fractalkine mediates T cell-dependent proliferation of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheum (2007) 0.97
Hepatitis B immunization of healthy elderly adults: relationship between naïve CD4+ T cells and primary immune response and evaluation of GM-CSF as an adjuvant. J Clin Immunol (2001) 0.97
Molecular fingerprint of interferon-gamma signaling in unstable angina. Circulation (2001) 0.95
Synoviocyte stimulation by the LFA-1-intercellular adhesion molecule-2-Ezrin-Akt pathway in rheumatoid arthritis. J Immunol (2008) 0.94
Age-related increase in autoantibodies. Lancet (1984) 0.92
The effects of age, thymectomy, and HIV Infection on alpha and beta TCR excision circles in naive T cells. J Immunol (2006) 0.91
Costimulatory pathways in rheumatoid synovitis and T-cell senescence. Ann N Y Acad Sci (2005) 0.90
Could accelerated aging explain the excess mortality in patients with seropositive rheumatoid arthritis? Arthritis Rheum (2010) 0.89
Atm and cellular response to DNA damage. Adv Exp Med Biol (2005) 0.89
Insufficient deactivation of the protein tyrosine kinase lck amplifies T-cell responsiveness in acute coronary syndrome. Circ Res (2009) 0.84
CD11b+CD28-CD4+ human T cells: activation requirements and association with HLA-DR alleles. J Immunol (1996) 0.81
The influence of age on T cell generation and TCR diversity. J Immunol (2005) 4.36
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med (2007) 3.81
Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum (2006) 3.64
Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med (2014) 3.46
Inflammation, immunity, and hypertension. Hypertension (2010) 3.43
T cell subset-specific susceptibility to aging. Clin Immunol (2008) 2.42
T cell development and receptor diversity during aging. Curr Opin Immunol (2005) 2.29
Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med (2012) 2.19
Understanding immunosenescence to improve responses to vaccines. Nat Immunol (2013) 2.09
Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum (2004) 2.08
Aging and T-cell diversity. Exp Gerontol (2007) 2.06
Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J Exp Med (2013) 1.96
Rheumatoid arthritis. Immunol Rev (2005) 1.94
Vessel-specific Toll-like receptor profiles in human medium and large arteries. Circulation (2008) 1.91
Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis. Arthritis Rheum (2005) 1.88
Th17 and Th1 T-cell responses in giant cell arteritis. Circulation (2010) 1.88
Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Circulation (2006) 1.77
Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque. Circ Res (2006) 1.77
BLyS and APRIL in rheumatoid arthritis. J Clin Invest (2005) 1.75
Regulation of T cell receptor signaling by activation-induced zinc influx. J Exp Med (2011) 1.73
T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation (2002) 1.72
Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med (2004) 1.70
Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation (2010) 1.68
Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci U S A (2003) 1.65
Epigenetic regulation of killer immunoglobulin-like receptor expression in T cells. Blood (2009) 1.62
T cell recognition and killing of vascular smooth muscle cells in acute coronary syndrome. Circ Res (2006) 1.62
Homeostatic control of T-cell generation in neonates. Blood (2003) 1.62
Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther (2003) 1.61
Immune activation caused by vascular oxidation promotes fibrosis and hypertension. J Clin Invest (2015) 1.55
Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci U S A (2009) 1.54
Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis. J Exp Med (2009) 1.54
NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs. J Clin Invest (2016) 1.53
TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J Exp Med (2006) 1.48
T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med (2004) 1.47
Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation (2007) 1.47
Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol (2006) 1.42
Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther (2005) 1.38
T-cell regulation in rheumatoid arthritis. Curr Opin Rheumatol (2004) 1.38
Developments in the scientific understanding of rheumatoid arthritis. Arthritis Res Ther (2009) 1.38
CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J Exp Med (2002) 1.38
Toll-like receptors 4 and 5 induce distinct types of vasculitis. Circ Res (2009) 1.37
Vessel wall-embedded dendritic cells induce T-cell autoreactivity and initiate vascular inflammation. Circ Res (2008) 1.35
Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res Cardiol (2006) 1.34
Rejuvenating the immune system in rheumatoid arthritis. Nat Rev Rheumatol (2009) 1.29
Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis (2006) 1.26
Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum (2008) 1.25
Inhibitory CD8+ T cells in autoimmune disease. Hum Immunol (2008) 1.23
DNA-dependent protein kinase catalytic subunit mediates T-cell loss in rheumatoid arthritis. EMBO Mol Med (2010) 1.23
Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms. J Immunol (2004) 1.23
Telomeres and immunological diseases of aging. Gerontology (2009) 1.22
Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis. J Immunol (2007) 1.22
CD28 loss in senescent CD4+ T cells: reversal by interleukin-12 stimulation. Blood (2002) 1.21
Telomere dysfunction, autoimmunity and aging. Aging Dis (2011) 1.20
Immune aging and autoimmunity. Cell Mol Life Sci (2012) 1.19
Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis. Am J Pathol (2002) 1.19
Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells. J Exp Med (2003) 1.18
Signaling pathways in aged T cells - a reflection of T cell differentiation, cell senescence and host environment. Semin Immunol (2012) 1.18
The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis. Arthritis Res Ther (2005) 1.17
Telomeres, immune aging and autoimmunity. Exp Gerontol (2006) 1.17
Dendritic cells in atherosclerotic disease. Clin Immunol (2009) 1.17
Formation of the killer Ig-like receptor repertoire on CD4+CD28null T cells. J Immunol (2002) 1.15
De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ Res (2003) 1.15
Chronic inflammation and aging: DNA damage tips the balance. Curr Opin Immunol (2012) 1.13
Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis. Circulation (2011) 1.12
Molecular basis for the loss of CD28 expression in senescent T cells. J Biol Chem (2002) 1.11
Regulatory T cells and the immune aging process: a mini-review. Gerontology (2013) 1.10
CD8+CD45RA+CCR7+FOXP3+ T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells. J Immunol (2012) 1.10
Uncoupling of T-cell effector functions by inhibitory killer immunoglobulin-like receptors. Blood (2006) 1.09
TLR-mediated induction of negative regulatory ligands on dendritic cells. J Mol Med (Berl) (2008) 1.09
The janus head of T cell aging - autoimmunity and immunodeficiency. Front Immunol (2013) 1.09
Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age. Proc Natl Acad Sci U S A (2012) 1.08
T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis. Arthritis Rheum (2005) 1.08
Lymphotoxin beta-mediated stimulation of synoviocytes in rheumatoid arthritis. Arthritis Rheum (2004) 1.08
The treatment of giant cell arteritis. Rev Neurol Dis (2008) 1.08
Clinicopathologic correlations in giant cell arteritis: a retrospective study of 107 cases. Ophthalmology (2009) 1.08
Distinct transcriptional control mechanisms of killer immunoglobulin-like receptors in natural killer (NK) and in T cells. J Biol Chem (2005) 1.07
ERK-dependent T cell receptor threshold calibration in rheumatoid arthritis. J Immunol (2009) 1.06
Cell-based immunotherapy with suppressor CD8+ T cells in rheumatoid arthritis. J Immunol (2005) 1.05
Toll-like receptors in giant cell arteritis. Clin Immunol (2005) 1.04
Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis. Am J Pathol (2004) 1.01
Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis. Arthritis Rheum (2006) 1.01
Epigenetic mechanisms of age-dependent KIR2DL4 expression in T cells. J Leukoc Biol (2008) 1.00
IL-7- and IL-15-mediated TCR sensitization enables T cell responses to self-antigens. J Immunol (2013) 0.99
Tissue trafficking patterns of effector memory CD4+ T cells in rheumatoid arthritis. Arthritis Rheum (2005) 0.99
Treating autoimmune disease by targeting CD8(+) T suppressor cells. Expert Opin Biol Ther (2009) 0.98
Fractalkine mediates T cell-dependent proliferation of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheum (2007) 0.97
Synoviocyte-mediated expansion of inflammatory T cells in rheumatoid synovitis is dependent on CD47-thrombospondin 1 interaction. J Immunol (2003) 0.97
The double life of NK receptors: stimulation or co-stimulation? Trends Immunol (2004) 0.97
Cutaneous metastasis as a initial presentation in advanced non-small cell lung cancer and its poor survival prognosis. J Cancer Res Clin Oncol (2012) 0.96
Giant cell arteritis: immune and vascular aging as disease risk factors. Arthritis Res Ther (2011) 0.95
The diagnosis of giant cell arteritis. Rev Neurol Dis (2007) 0.95
Vascular damage in giant cell arteritis. Autoimmunity (2009) 0.95
Synoviocyte stimulation by the LFA-1-intercellular adhesion molecule-2-Ezrin-Akt pathway in rheumatoid arthritis. J Immunol (2008) 0.94
Genetics of rheumatoid arthritis: Is there a pattern predicting extraarticular manifestations? Arthritis Rheum (2004) 0.94
Dynamic immune cell accumulation during flow-induced atherogenesis in mouse carotid artery: an expanded flow cytometry method. Arterioscler Thromb Vasc Biol (2012) 0.93
Mechanisms of immunosenescence: lessons from models of accelerated immune aging. Ann N Y Acad Sci (2012) 0.93
T-cell co-stimulatory pathways in autoimmunity. Arthritis Res Ther (2008) 0.91
Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis. World J Gastroenterol (2013) 0.91
Macrophages in vascular inflammation--From atherosclerosis to vasculitis. Autoimmunity (2015) 0.91